학술논문

De Novo Prion Aggregates Trigger Autophagy in Skeletal Muscle
Document Type
article
Source
Journal of Virology. 88(4)
Subject
Biological Sciences
Medical Physiology
Biomedical and Clinical Sciences
Neurosciences
Transmissible Spongiform Encephalopathy (TSE)
Rare Diseases
Neurodegenerative
Brain Disorders
Infectious Diseases
Emerging Infectious Diseases
2.1 Biological and endogenous factors
Aetiology
Underpinning research
1.1 Normal biological development and functioning
Neurological
Animals
Autophagy
Blotting
Western
DNA Primers
Endoplasmic Reticulum Chaperone BiP
Heat-Shock Proteins
Immunohistochemistry
Mice
Mice
Transgenic
Muscle Cells
Muscle
Skeletal
Polymerase Chain Reaction
Prion Diseases
Agricultural and Veterinary Sciences
Medical and Health Sciences
Virology
Agricultural
veterinary and food sciences
Biological sciences
Biomedical and clinical sciences
Language
Abstract
In certain sporadic, familial, and infectious prion diseases, the prion protein misfolds and aggregates in skeletal muscle in addition to the brain and spinal cord. In myocytes, prion aggregates accumulate intracellularly, yet little is known about clearance pathways. Here we investigated the clearance of prion aggregates in muscle of transgenic mice that develop prion disease de novo. In addition to neurodegeneration, aged mice developed a degenerative myopathy, with scattered myocytes containing ubiquitinated, intracellular prion inclusions that were adjacent to myocytes lacking inclusions. Myocytes also showed elevated levels of the endoplasmic reticulum chaperone Grp78/BiP, suggestive of impaired protein degradation and endoplasmic reticulum stress. Additionally, autophagy was induced, as indicated by increased levels of beclin-1 and LC3-II. In C2C12 myoblasts, inhibition of autophagosome maturation or lysosomal degradation led to enhanced prion aggregation, consistent with a role for autophagy in prion aggregate clearance. Taken together, these findings suggest that the induction of autophagy may be a central strategy for prion aggregate clearance in myocytes. IMPORTANCE In prion diseases, the prion protein misfolds and aggregates in the central nervous system and sometimes in other organs, including muscle, yet the cellular pathways of prion aggregate clearance are unclear. Here we investigated the clearance of prion aggregates in the muscle of a transgenic mouse model that develops profound muscle degeneration. We found that endoplasmic reticulum stress pathways were activated and that autophagy was induced. Blocking of autophagic degradation in cell culture models led to an accumulation of aggregated prion protein. Collectively, these findings suggest that autophagy has an instrumental role in prion protein clearance.